| Dr Diane W Wara, MD | |
|
400 Parnassus Ave, San Francisco, CA 94143-2202 | |
| (415) 476-2491 | |
| (415) 502-7540 |
| Full Name | Dr Diane W Wara |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 400 Parnassus Ave, San Francisco, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750317004 | NPI | - | NPPES |
| 00A237430 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | A23743 (California) | Primary |
| 208000000X | Pediatrics | A23743 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Diane W Wara, MD 1635 Divisadero Street, Suite 625, Box 1821, San Francisco, CA 94143-0001 Ph: (415) 476-4029 | Dr Diane W Wara, MD 400 Parnassus Ave, San Francisco, CA 94143-2202 Ph: (415) 476-2491 |
News Archive
The U.S. Food and Drug Administration recently announced the authorization of FerriScan R2-MRI to be marketed as an imaging companion diagnostic device for the safe and effective use of Exjade in patients with non-transfusion-dependent thalassemia.
NewCardio, Inc., a cardiac diagnostic technology provider, today announced that it has entered into a new line of credit with three of its existing shareholders, one of which is represented on the Board of Directors, to strengthen its financial position. This will allow the company further time to fully commercialize its lead solution, QTinnoâ˘.
For decades, the traditional practice in animal testing has been standardization, but a study involving Purdue University has shown that adding as few as two controlled environmental variables to preclinical mice tests can greatly reduce costly false positives, the number of animals needed for testing and the cost of pharmaceutical trials.
An augmented reality project, created by a Manchester start-up is being used in hospitals to help with heart problems.
Do metastatic cancer tumors "break bad" or are they "born bad"? This question is an essential mystery in cancer early detection and treatment. Lacking a clear answer, patients are given the same aggressive therapies when small, abnormal clusters of cells are discovered early, even though they might well be harmless.
› Verified 1 days ago
Dr. Kathryn Rachel Davis, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 505 Parnassus Ave # 0110, University Of California San Francisco, M691, San Francisco, CA 94143 Phone: 415-476-6245 | |
Dr. David Michael Gordon, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 505 Parnassus Ave # M696, Box 0110, San Francisco, CA 94143 Phone: 415-353-1000 | |
Jayme Congdon, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1500 Owens St, San Francisco, CA 94158 Phone: 415-476-1000 | |
Laurie Song, Pediatrics Medicare: Medicare Enrolled Practice Location: 550 16th St, San Francisco, CA 94158 Phone: 415-514-4079 Fax: 415-476-5354 | |
Ms. Tatiana Goldstein, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 525 Spruce Street, Suite 3, San Francisco, CA 94118 Phone: 415-668-8900 Fax: 415-668-1695 | |
John T Tsukahara, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2340 Clay St, 3rd Floor, San Francisco, CA 94115 Phone: 415-600-1111 | |
William Bernard Solomon, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 45 Castro Street, Suite 232, San Francisco, CA 94114 Phone: 415-565-6810 Fax: 415-565-6844 |